Chemotherapy and targeted therapy after whole-brain radiotherapy may improve survival in RPA class II/III patients with brain metastases from breast cancer

被引：0
|
作者：
Zhang, Q. [1 ]
Chen, J. [1 ]
Cai, G. [1 ]
Yang, Z. [1 ]
Chen, J. [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P3-12-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-12-12
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder
    Rades, Dirk
    Dziggel, Liesa
    Manig, Lisa
    Janssen, Stefan
    Mai Trong Khoa
    Vuong Ngoc Duong
    Vu Huu Khiem
    Schild, Steven E.
    IN VIVO, 2018, 32 (03): : 633 - 636
  • [42] Incidence of brain atrophy and dementia after whole-brain radiotherapy in patients with brain metastases: A prospective study
    Shibamoto, Y.
    Baba, F.
    Oda, K.
    Tomita, N.
    Hayashi, S.
    Kokubo, M.
    Ishihara, S.
    Ito, Y.
    Kobayashi, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S86 - S87
  • [43] Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
    Frisk, Gabriella
    Tinge, Beatrice
    Ekberg, Sara
    Eloranta, Sandra
    Backlund, L. Magnus
    Lidbrink, Elisabet
    Smedby, Karin E.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) : 887 - 896
  • [44] Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
    Gabriella Frisk
    Beatrice Tinge
    Sara Ekberg
    Sandra Eloranta
    L. Magnus Bäcklund
    Elisabet Lidbrink
    Karin E. Smedby
    Breast Cancer Research and Treatment, 2017, 166 : 887 - 896
  • [45] Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer
    Cao, K. I.
    Lebas, N.
    Gerber, S.
    Levy, C.
    Le Scodan, R.
    Bourgier, C.
    Pierga, J. -Y.
    Gobillion, A.
    Savignoni, A.
    Kirova, Y. M.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 89 - 94
  • [46] Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors
    Kouvaris, John R.
    Miliadou, Anthi
    Kouloulias, Vassilis E.
    Kolokouris, Dimitrios
    Balafouta, Myrsini J.
    Papacharalampous, Xenofon N.
    Vlahos, Lambros J.
    ONKOLOGIE, 2007, 30 (07): : 361 - 366
  • [47] Brain Metastases from Breast Cancer - Factors Influencing Outcome after Whole Brain Radiotherapy
    O'Toole, L.
    Adlard, J. W. A.
    Kumar, S.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 275 - 275
  • [48] Predicting Survival after Whole-Brain Irradiation for Cerebral Metastases from Prostate Cancer
    Bartscht, Tobias
    Rades, Dirk
    ANTICANCER RESEARCH, 2014, 34 (08) : 4357 - 4360
  • [49] From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
    Protopapa, Maria
    Kouloulias, Vassilis
    Nikoloudi, Styliani
    Papadimitriou, Christos
    Gogalis, Giannis
    Zygogianni, Anna
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [50] Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
    Addeo, Raffaele
    Sperlongano, Pasquale
    Montella, Liliana
    Vincenzi, Bruno
    Carraturo, Marco
    Iodice, Patrizia
    Russo, Paola
    Parlato, Ciro
    Salzano, Antonio
    Cennamo, Gregorio
    Lombardi, Angela
    Sperlongano, Rossella
    Del Prete, Salvatore
    Caraglia, Michele
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 603 - 609
12345